CLINICAL_TRIALS
trial_result
· 2018-02-05
Clinical Trial Update: SPACE Trial: Pyridostigmine vs Placebo in SMA Types 2, 3 and 4 [Phase 2]
Summary
Phase 2 trial comparing pyridostigmine to placebo in Spinal Muscular Atrophy types 2, 3, and 4 has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UMC Utrecht | Conditions: Spinal Muscular Atrophy, SMA | Phase 2 | Status: COMPLETED